Losartan Cost in Arkansas 2026: Cash Pay, Medicaid, Insurance, and Compounded Options

What Generic Losartan Actually Costs in Arkansas Right Now

Generic losartan costs approximately $10 per month for a 30-day supply of 50 mg tablets at most Arkansas retail pharmacies in 2026 when you present a free discount coupon or pay cash. That figure comes from aggregated pricing data across Walmart, Walgreens, CVS, and independent pharmacies in cities including Little Rock, Fayetteville, Fort Smith, and Jonesboro.

The Merck brand-name product, Cozaar, carries a list price near $80 per month, but the vast majority of patients in Arkansas fill the generic. Pharmacies including Walmart and Costco often stock losartan potassium 25 mg, 50 mg, and 100 mg tablets at prices below $10 with a club membership or a printed GoodRx coupon. The price difference between chain pharmacies and independent compounding pharmacies is meaningful. A 90-day supply of 100 mg tablets at a large-chain retailer in Little Rock may run $22 to $28 cash pay, while the same quantity at a smaller independent could reach $35 to $40 without a discount code.

Losartan belongs to the angiotensin II receptor blocker (ARB) class. The FDA first approved the drug in 1995 under the brand name Cozaar for hypertension, and generic versions entered the U.S. market in 2010 after patent expiration. [1] The drug's mechanism, blocking the AT1 receptor and lowering peripheral vascular resistance, is well documented across decades of randomized trial data. [2]

The following pricing framework applies to Arkansas residents in 2026:

| Supply | Dose | Estimated Cash Price | Source/Method | |--------|------|----------------------|---------------| | 30-day | 50 mg | $4 to $10 | GoodRx coupon, Walmart $4 list | | 30-day | 100 mg | $8 to $15 | GoodRx coupon, chain pharmacy | | 90-day | 50 mg | $10 to $22 | Mail-order or big-box retailer | | 90-day | 100 mg | $18 to $30 | Mail-order or big-box retailer |

Bottom line: most Arkansas patients paying without insurance should target $10 or less per month for a standard 50 mg daily dose by using a coupon at the time of purchase.

Arkansas Medicaid Coverage for Losartan

Arkansas Medicaid covers losartan, but the program attaches a limited prior authorization requirement in most clinical scenarios. Straightforward hypertension claims may process without PA if the prescriber documents the diagnosis correctly and the dose falls within the preferred range listed on the Arkansas Medicaid Preferred Drug List (PDL). Diabetic nephropathy and heart failure with reduced ejection fraction indications carry stricter documentation requirements.

The Arkansas Division of Medical Services administers the state Medicaid program, and its PDL places ARBs in the same tier as ACE inhibitors for first-line hypertension. [3] A prescriber who submits a PA request for a patient with type 2 diabetes and persistent albuminuria (urine albumin-to-creatinine ratio above 300 mg/g) should attach laboratory documentation, most recent HbA1c, and any prior ACE inhibitor trial notes. Approval time runs three to five business days under standard review, or 24 hours under expedited review for urgent clinical need.

The American Diabetes Association's 2024 Standards of Care state: "For people with type 1 or type 2 diabetes and hypertension, either an ACE inhibitor or angiotensin receptor blocker is recommended as first-line therapy." [4] That guideline language strengthens a PA request for losartan when the prescriber attaches the ADA citation directly in the PA narrative.

Arkansas Medicaid beneficiaries who receive a PA denial have 30 days to file a formal appeal. The state's fair hearing process allows telephone or written appeals, and a physician or telehealth provider may submit clinical letters on behalf of the patient. Copays under Arkansas Medicaid for preferred generic drugs run $0.65 to $3.00 per fill depending on eligibility category, making losartan one of the most affordable drugs on the formulary once PA is granted.

How Insurance Plans Price Losartan in Arkansas

Private insurance plans offered through Arkansas Blue Cross Blue Shield, QualChoice, and the Arkansas Health Insurance Marketplace place generic losartan on Tier 1 in most formularies, which translates to a copay of $0 to $15 per 30-day fill. Employer-sponsored plans administered by national carriers such as UnitedHealthcare, Aetna, and Cigna mirror this tiering in Arkansas.

Medicare Part D plans operating in Arkansas in 2026 list losartan as a Tier 1 generic on all four major standalone Part D plan formularies. [5] Under the Inflation Reduction Act caps now fully phased in for 2025 to 2026, out-of-pocket costs for Medicare enrollees on standard generic drugs are capped at $2,000 annually across all Part D drugs, which makes losartan effectively zero-cost for most patients in months after deductible.

One practical note. Patients who are uninsured or whose plan does not cover a specific losartan strength should not assume the insurance price beats cash pay. At many Arkansas pharmacies, a Tier 2 or non-preferred generic copay of $30 to $45 exceeds the $4 to $10 cash price. Always ask the pharmacist to run a coupon comparison before applying insurance for generic medications.

Compounded Losartan in Arkansas: What Is Legal and What It Costs

Compounded losartan is legal in Arkansas when prepared by a state-licensed 503A pharmacy operating under a valid patient-specific prescription from a licensed prescriber. [6] The term "503A" refers to the section of the Federal Food, Drug, and Cosmetic Act that governs traditional compounding pharmacies, as distinguished from 503B outsourcing facilities that produce large batches for hospital use.

In practice, Arkansas has several 503A compounding pharmacies that prepare losartan in oral suspension formulations (for patients with dysphagia or pediatric dosing needs), combination formulations, and customized doses not commercially available. A compounded losartan oral suspension at 2.5 mg/mL for a pediatric patient with chronic kidney disease is a common clinical use case that commercial tablets cannot easily address.

Cost for compounded losartan varies by pharmacy and formulation. Some HealthRX-affiliated telehealth patients who qualify under manufacturer assistance programs have received compounded losartan at no out-of-pocket cost. Standard pricing across Arkansas 503A pharmacies for a 30-day supply of compounded oral suspension ranges from $25 to $60 depending on volume and base concentration.

A few points on legality deserve direct answers. The Arkansas State Board of Pharmacy licenses and inspects 503A pharmacies. Compounding losartan for office stock or without a patient-specific prescription is not permitted under 503A rules. [7] Patients should verify that their compounding pharmacy holds a current Arkansas license before filling a prescription. The Arkansas State Board of Pharmacy license lookup is available at the Board's official portal.

Losartan Savings Cards and Discount Programs Available in Arkansas

Three categories of savings programs reduce losartan costs for Arkansas residents who do not qualify for Medicaid.

Manufacturer card. Merck offers a savings card for brand-name Cozaar that can reduce the cost to as low as $5 per fill for commercially insured patients. The card is not valid for Medicare or Medicaid beneficiaries. Arkansas patients with private insurance whose plan places Cozaar on a non-preferred tier benefit most from this program. Enrollment is through Merck's patient assistance portal.

Third-party discount coupons. GoodRx, RxSaver, and NeedyMeds generate real-time price quotes at specific Arkansas zip codes. For 50 mg losartan (30 tablets) in zip code 72201 (Little Rock), GoodRx quotes $4 to $7 at Walmart and Sam's Club. Showing the coupon on a smartphone at the pharmacy counter is sufficient. These coupons are not insurance and cannot be combined with Medicaid or Medicare Part D.

Patient Assistance Programs (PAPs). Patients with household incomes below 200 to 400% of the federal poverty level may qualify for free brand-name Cozaar through Merck's Patient Assistance Program. The application requires prescriber signature, income documentation, and proof of Arkansas residency. Processing time runs three to six weeks for initial approval.

The LIFE trial (Losartan Intervention For Endpoint Reduction in Hypertension, published in The Lancet in 2002, N=9,193) demonstrated that losartan 50 mg to 100 mg daily reduced the primary composite of cardiovascular death, stroke, and myocardial infarction by 13% relative to atenolol 50 mg to 100 mg daily (P=0.021) over a mean 4.8-year follow-up, with superior stroke prevention as the dominant driver. [8] That evidence base supports the clinical rationale for maintaining uninterrupted access to losartan, which makes cost management a genuine public-health priority for Arkansas providers.

Getting a Losartan Prescription via Telehealth in Arkansas

Telehealth prescribing of losartan is legal in Arkansas for both new and established patients under current state law. Arkansas Act 543 of 2021 and subsequent amendments by the Arkansas State Medical Board permit prescribing via audio-visual telehealth for most non-controlled medications when the provider completes an appropriate medical evaluation. [9]

A telehealth visit for hypertension management in Arkansas typically takes 15 to 20 minutes. The prescriber reviews blood pressure logs, kidney function labs (serum creatinine, potassium, eGFR), and medication history before sending a prescription electronically to the patient's chosen Arkansas pharmacy. Monitoring labs are required before initiating losartan and at four to eight weeks after dose adjustment, consistent with the 2023 ESH hypertension guidelines recommendation to check serum potassium and creatinine within two to four weeks of starting any renin-angiotensin-aldosterone system blocker. [10]

HealthRX provides telehealth-based hypertension management to Arkansas residents. After a virtual consultation, your prescriber sends the losartan prescription electronically to any Arkansas pharmacy, or coordinates a compounded formulation if a standard tablet is clinically unsuitable.

Clinical Evidence Supporting Losartan for Arkansas Patients

Losartan's evidence base spans hypertension, diabetic nephropathy, and heart failure with reduced ejection fraction. The three largest Arkansas-relevant clinical contexts are:

Hypertension. The LIFE trial (N=9,193) showed losartan's superiority over atenolol for stroke prevention, with a 25% relative risk reduction in fatal and non-fatal stroke (P<0.001). [8] The Eighth Joint National Committee (JNC 8) guideline lists ARBs including losartan as first-line agents for hypertension in patients with chronic kidney disease and in non-Black adults. [11]

Diabetic nephropathy. The RENAAL trial (N=1,513, NEJM 2001) showed losartan 50 mg to 100 mg daily reduced the risk of the composite endpoint (doubling of serum creatinine, end-stage renal disease, or death) by 16% relative to placebo (P=0.02) over a mean 3.4-year follow-up in patients with type 2 diabetes and nephropathy. [12] Arkansas has one of the highest rates of diabetes prevalence in the nation, with 13.6% of adults affected according to 2023 CDC data. [13] That burden makes RENAAL-supported losartan use particularly relevant to Arkansas prescribers.

Heart failure. The ELITE II trial and the Val-HeFT data inform ARB use in heart failure patients intolerant of ACE inhibitors. The 2022 AHA/ACC/HFSA Heart Failure Guideline gives ARBs a Class I recommendation for patients with heart failure with reduced ejection fraction who cannot tolerate ACE inhibitors because of cough or angioedema. [14]

Dr. Bryan Williams, co-author of the 2023 European Society of Hypertension guidelines, stated in that document: "RAS inhibitors remain the cornerstone of antihypertensive treatment in patients with diabetes, CKD, or heart failure because the evidence of organ protection extends well beyond blood pressure reduction alone." [10]

Side Effects and Monitoring Requirements Arkansas Patients Should Know

Losartan is generally well tolerated, but three safety concerns require proactive monitoring.

Hyperkalemia is the most common serious adverse effect. Baseline potassium above 5.0 mEq/L is a contraindication to starting the drug. For Arkansas patients with CKD stage 3b or worse (eGFR <45 mL/min/1.73 m2), potassium should be rechecked within two to four weeks of dose initiation or increase. [10]

Acute kidney injury risk increases when losartan is combined with NSAIDs, which are heavily purchased over the counter. Arkansas patients using ibuprofen or naproxen regularly should be counseled to monitor for decreased urine output and rising creatinine.

Fetal toxicity is the most serious absolute contraindication. Losartan carries an FDA black box warning against use during pregnancy (second and third trimesters) because of direct fetal renal toxicity and oligohydramnios. [1] Women of reproductive age receiving losartan in Arkansas should receive documented counseling and use effective contraception.

Losartan does not cause the dry cough associated with ACE inhibitors, which is its main tolerability advantage. The LIFE trial confirmed this distinction, with cough rates under 5% in the losartan arm versus over 10% in ACE inhibitor crossover populations in contemporaneous studies. [8]

Step-by-Step Guide to Getting the Lowest Losartan Price in Arkansas

1. Confirm your diagnosis and dose with your prescriber via in-person or telehealth visit.
2. Ask for a 90-day supply rather than 30-day to reduce per-unit cost.
3. Check GoodRx, RxSaver, and Blink Health at your specific Arkansas zip code before heading to the pharmacy.
4. If you have Medicaid, confirm PA status before filling to avoid unexpected denials.
5. If you have private insurance, ask the pharmacist whether the coupon price beats your copay. It often does for generics.
6. If you have Medicare Part D, confirm your plan's current-year formulary tier; all major AR Part D plans list losartan at Tier 1 in 2026.
7. If a standard tablet is not clinically appropriate, ask your telehealth or in-office provider about a 503A compounded formulation.
8. Apply for Merck's PAP if your income qualifies and you require brand-name Cozaar.

The average Arkansas patient on a standard 50 mg once-daily dose should pay no more than $10 per month using steps 3 or 5 above.